Atrial Fibrillation Clinical Trials in Tampa, Florida

5 studies are recruiting for atrial fibrillation in Tampa, Florida right now. Each one is listed on ClinicalTrials.gov, the public registry the research teams themselves file with. TrialBoost is not a doctor, a research site, or a study sponsor: the research team decides who takes part.

Search these by distance from you

Studies now recruiting

  1. The Fourth Left Atrial Appendage Occlusion Study

    LAAOS-4 aims to determine if catheter-based endovascular left atrial appendage occlusion prevents ischemic stroke or systemic embolism in participants with atrial fibrillation, who remain at high risk of stroke, despite receiving ongoing treatment with oral anticoagulation.

    Stage
    Not phased
    Ages
    18 and older
    Site
    The University of South Florida, Tampa, Florida
    Locations
    150 in total
    Run by
    Hamilton Health Sciences Corporation

    See if you can join NCT05963698 on ClinicalTrials.gov

  2. PULSED AF Post-Approval Study

    PULSED AF PAS is a prospective, global, multi-center, non-randomized, observational trial. Subjects will be treated with the PulseSelect™ PFA System and followed through 36 months.

    Stage
    Not phased
    Ages
    18 and older
    Site
    University of South Florida Health (USF), Tampa, Florida
    Locations
    23 in total
    Run by
    Medtronic Cardiac Ablation Solutions

    See if you can join NCT06578104 on ClinicalTrials.gov

  3. Tracking Results of Ablations to Combat AF Registry Generation 2

    The primary objective of the TRAC-AF Registry is to capture real-world safety and effectiveness data on AtriCure devices used to conduct open concomitant and/or hybrid ablation, and management of the LAA concomitant to a cardiac ablation.

    Stage
    Not phased
    Ages
    18 and older
    Site
    St. Joseph's Hospital (BayCare), Tampa, Florida
    Locations
    29 in total
    Run by
    AtriCure, Inc.

    See if you can join NCT05111015 on ClinicalTrials.gov

  4. Anticoagulation in ICH Survivors for Stroke Prevention and Recovery

    Primary Aim: To determine if apixaban is superior to aspirin for prevention of the composite outcome of any stroke (hemorrhagic or ischemic) or death from any cause in patients with recent ICH and atrial fibrillation (AF). Secondary Aim: To determine if apixaban, compared with aspirin, results in b…

    Stage
    Phase 3
    Ages
    18 and older
    Site
    Tampa General Hospital, Tampa, Florida
    Locations
    187 in total
    Run by
    Yale University

    See if you can join NCT03907046 on ClinicalTrials.gov

  5. Chloroquine for Patients With Symptomatic Persistent Atrial Fibrillation: A Prospective Pilot Study

    The goal of this pilot study is to explore the efficacy of chloroquine in terminating persistent AF and assess its potential role as a pharmacological cardioversion agent for the management of AF.

    Stage
    Phase 2
    Ages
    18 and older
    Site
    University of South Florida, Tampa, Florida
    Run by
    University of South Florida

    See if you can join NCT02932007 on ClinicalTrials.gov

How to read this page. Every study here comes from ClinicalTrials.gov, the public registry that research teams are required to file with. We have summarised each one in plain language and shown where it is running. We have not changed what any study says it is doing.

What TrialBoost is. We help people find research that might suit them, and, if they ask us to, we pass their details to the research team running it. We are not a doctor, a research site, or a study sponsor, and we do not decide who takes part in anything. Joining costs nothing and you can change your mind at any point.

Paid placement. Some studies pay us when someone asks to be connected to them. Those are labelled Sponsored wherever they appear, and they only appear when they match what you were actually looking for.